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Summary
Although psoriasis is strongly associated with certain
human leukocyte antigens (HLAs), evidence for linkage
to HLA markers has been limited. The objectives of this
study were (1) to provide more definitive evidence for
linkage of psoriasis to HLA markers in multiplex fam-
ilies; (2) to compare the major HLA risk alleles in these
families with those determined by previous case-control
studies; and (3) to localize the gene more precisely. By
applying the transmission/disequilibrium test (TDT) and
parametric linkage analysis, we found evidence for link-
age of psoriasis to HLA-C, -B, -DR, and -DQ, with
HLA-B and -C yielding the most-significant results.
Linkage was detectable by parametric methods only
when marker-trait disequilibrium was considered. Case-
control association tests and the TDT identified alleles
belonging to the EH57.1 ancestral haplotype as the ma-
jor risk alleles in our sample. Among individuals carrying
recombinant ancestral haplotypes involving EH57.1, the
class I markers were retained selectively among affecteds
four times more often than among unaffecteds; among
the few affected individuals carrying only the class II
alleles from the ancestral haplotype, all but one also
carried Cw6. These data show that familial and “spo-
radic” psoriasis share the same risk alleles. They also
illustrate that substantial parametric linkage information
can be extracted by accounting for linkage disequilib-
rium. Finally, they strongly suggest that a major suscep-
tibility gene resides near HLA-C.
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Introduction
Psoriasis (MIM 177900) is a common, human leukocyte
antigen (HLA)–associated skin disease affecting 1%–2%
of the Caucasian population (Christophers and Sterry
1993). There is increasing evidence that immune-system
activation plays a central role in the keratinocyte hy-
perproliferation that is an obvious feature of psoriasis.
The marked efficacy of cyclosporine A treatment (Ellis
et al. 1991) has focused attention on actively dividing
T cells that accumulate in psoriatic lesions (Morganroth
et al. 1991). In addition, a variety of other antigen-pre-
senting, effector, and inflammatory cells are also present
in psoriatic skin (de Boer et al. 1994), and keratinocytes
themselves may modulate immune functions via a va-
riety of mechanisms (Barker et al. 1991).
Candidate psoriasis-susceptibility loci recently have
been identified in the HLA region, as well as on chro-
mosomes 2p, 4q, 8q, 16q, 17q, and 20p (Tomfohrde et
al. 1994; Matthews et al. 1996; Nair et al. 1997; Trem-
bath et al. 1997). Independent confirmation has been
reported for the HLA region (Nair et al. 1997; Trembath
et al. 1997), 17q (Tomfohrde et al. 1994; Nair et al.
1997), and 20p, for which two groups (Nair et al. 1997;
Trembath et al. 1997) reported evidence for linkage to
markers within a 10-cM region. All disease genes remain
to be identified. Consistent with expectations for a mul-
tifactorial disorder (Lander and Schork 1994), both
HLA association and familial aggregation increase
markedly with decreasing age at onset (Henseler and
Christophers 1985).
Numerous HLA phenotypes, corresponding to alleles
at the HLA-A, -B, -C, -DRB1, -DQA1, and -DQB1 loci,
have been associated with psoriasis. Among these, the
class I phenotypes Cw6 and B57 have been most con-
sistently reported worldwide (see Elder et al. 1994). The
alleles that correspond to these Cw6 and B57 phenotypes
are in linkage disequilibrium in normal individuals and
compose the proximal class I end of an ancestral hap-
lotype, termed “EH57.1” (Degli-Esposti et al. 1992).
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The class II side of the EH57.1 ancestral haplotype con-
tains the DRB1*0701, DQA1*0201, and DQB1*03032
alleles, which also display strong associations with pso-
riasis (Schmitt-Egenolf et al. 1993). A recent analysis of
ancestral haplotypes has implicated the class I end of
this haplotype to be the region that contains the major
HLA-linked determinant of psoriasis susceptibility
(Schmitt-Egenolf et al. 1996). Two additional HLA-B
alleles (B13 and B37) known to be in linkage disequi-
librium with Cw6 have been associated with psoriasis
(see Elder et al. 1994). Nonetheless, many affected in-
dividuals do not carry Cw6 or any detectable portion
of the EH57.1 ancestral haplotype.
These studies suggest at least three possible genetic
etiologies for psoriasis. First, more than one allele at a
single locus could confer susceptibility. Second, alleles
at more than one locus within the HLA region could
confer susceptibility. Third, the “true” disease locus
could be linked to, but separate from, one or more
known HLA genes (Thomson and Bodmer 1977). The
available HLA-association data favor the third possi-
bility, but they do not rule out the other two possibilities.
In a recent genome scan performed in our laboratory
(Nair et al. 1997), evidence of linkage to HLA was pres-
ent over a rather broad interval and was not as robust
as might be expected, given the strong HLA associations
characteristic of psoriasis. Thus, the objectives of the
current study were threefold: (1) to use linkage-dise-
quilibrium studies to provide stronger evidence for link-
age to HLA; (2) to determine whether the same HLA
risk alleles are involved in familial and in sporadic pso-
riasis; and (3) to localize the disease allele more precisely.
Subjects and Methods
Juvenile-onset probands (!40 years of age) were iden-
tified from billing records, referrals, or clinic encounters
and were used to identify sibships with at least two af-
fected members. Most individuals were residents of
southeast Michigan or northern Germany. The age-at-
onset criterion was based on the observed bimodal age-
at-onset distribution characteristic of psoriasis (Henseler
and Christophers 1985). No age-at-onset criterion was
applied to other affected family members. All individuals
were examined by a dermatologist and were considered
to be affected if they displayed two or more character-
istic skin, scalp, nail, or joint lesions (Christophers and
Sterry 1993) or if a single lesion occupied 11% of the
total body surface area. Parents and siblings of affected
sib pairs were examined, and blood was sampled when-
ever possible. Pedigrees that extended beyond the nu-
clear family were analyzed when at least four affected
first- or second-degree relatives were available for study.
Each individual ascertained under these criteria was in-
cluded in the analysis (Cannings and Thompson 1977),
and no individuals were excluded on the basis of marker
data. Informed consent was obtained from all subjects,
under protocols approved by the institutional review
boards of the University of Michigan and the University
of Kiel. These families were essentially the same as those
used for our genome scan (Nair et al. 1997).
HLA-A and -B were typed serologically, and HLA-C,
-DRB1, and -DQB1 were typed by use of DNA-based
techniques (Kimura and Sasazuki 1993; Bunce et al.
1994). Typing was performed on suspensions of fresh
leukocytes or immortalized lymphoblasts, prepared as
described elsewhere (Nair et al. 1995). The nomencla-
ture used for serologically defined HLA specificities is
the name of the locus followed by the number of the
specificity (e.g., B57) and, for genotyped alleles, the
name of the locus followed by an asterisk and the num-
ber of the allele (e.g., Cw*0602 or DQB1*03032). For
class II phenotypes, the nomenclature is complicated by
the fact that antigens are coded by two polymorphic
loci. For example, the phenotype DQ9 is coded by the
DQA1*0201 and DQB1*03032 alleles (Bodmer et al.
1995). For consistency, we used serological designations
for class I alleles and genotypic designations for class II
alleles, even though HLA-C was typed by use of DNA-
based techniques.
Parametric linkage was assessed by use of the LINK-
AGE package (Lathrop et al. 1984). The prevalence of
psoriasis (f) varies within the range of .01–.028 in Cau-
casian populations (Johnson 1978; Christophers and
Sterry 1993). We assumed . The disease-allelef  .01
frequency (p) was assumed to be .05 under dominance
and .25 under recessivity, with 10% of psoriasis cases
attributable to nongenetic causes. These assumptions are
very similar to those recommended for linkage analysis
of complex-trait data (Risch et al. 1989). Under Hardy-
Weinberg equilibrium, these assumptions yielded the
penetrances and , for thef  f  .092 f  .0011DD Dd dd
dominant model, and andf  .144 f  f DD Dd dd
, for the recessive model. Increasing f to .02 (under.0011
the assumption of Hardy-Weinberg equilibrium) had lit-
tle or no effect on the results (for supplemental data, see
the Psoriasis Genetics Research web site).
The LINKAGE package can be programmed to “rec-
ognize” the existence of linkage disequilibrium between
the marker and the trait (Terwilliger and Ott 1994).
Otherwise, the program assumes that either phase be-
tween the marker and the disease alleles is equally likely,
in phase-unknown matings. We estimated disease-
marker haplotype frequencies by use of the EH program
(Terwilliger and Ott 1994) and then used these frequen-
cies to incorporate marker-trait disequilibrium into our
parametric linkage calculations, following the same pro-
cedure for both the null and the alternative hypotheses.
Haplotype frequencies were estimated by comparison of
an unrelated group of local controls (189 U.S. and 124
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Table 1
Selected Characteristics of the Study Cohorts
Characteristic U.S. Cohort German Cohort
General:
No. of extended pedigrees 16 22
No. of nuclear sib-pair
families 33 16
Affected/total males (%) 79/182 (43.4) 66/159 (41.5)
Affected/total females (%) 97/223 (43.5) 77/184 (41.8)
Affected/total individuals (%) 176/405 (43.5) 143/343 (41.7)
Mean age at onset (years) 19.2 21.4
No. of affected children, by pa-
rental affected status:a
One parent affected (%) 42 (75) 23 (65.7)
Neither parent affected (%) 14 (25) 8 (22.9)
Both parents affected (%) 0 (0) 4 (11.4)
Total 56 35
No. of affected parents/total no.
of parents (%) 42/112 (37.5) 31/70 (44.2)
a Includes only cases for which both parents were evaluated. For
cases of sibships with multiple affected individuals, parental status was
counted only once per sibship.
German) with either case sample 1 (54 U.S. and 107
German unrelated affected pedigree members typed at
all five HLA loci) or case sample 2 (237 German un-
related psoriatics typed for HLA-A and HLA-B). An in-
dividual other than the proband was chosen for inclu-
sion in case sample 1 only when he or she was typed
more completely than the proband. HLA allele sharing
in affected sib pairs was analyzed by use of SIBPAIR
(Satsangi et al. 1996).
Transmission of HLA alleles from heterozygous par-
ents to affected offspring was assessed by use of the
transmission/disequilibrium test (TDT). The biallelic
TDT (Spielman et al. 1993) was performed for all alleles
at loci for which the number of scoreable transmission
plus nontransmission events was 110. A multiallelic ex-
tension of the TDT also was employed (Spielman and
Ewens 1996). The TDT was used both as a test of linkage
(by scoring all informative parent-offspring trios) and as
a test of linkage disequilibrium (by scoring only one
randomly chosen trio per pedigree). The recommenda-
tions of Curtis and Sham (Curtis and Sham 1995) were
followed when a parental genotype for a trio was
missing.
Tests for HLA associations with the psoriasis phe-
notype were performed by comparison of the HLA phe-
notypes of the individuals in case sample 1 with those
of the unrelated local controls described above, by use
of contingency tables. Significance tests were per-2# 2
formed only for HLA phenotypes reported in the liter-
ature to be associated with psoriasis (Svejgaard and Ry-
der 1994).
HLA haplotypes were estimated by use of the HAP-
CHILD program of the Genetic Analysis System pack-
age, version 2.0 (Young 1993), and were validated by
visual inspection of pedigrees. Individuals were consid-
ered to carry the class I end of the EH57.1 haplotype if
at least one of their HLA haplotypes was positive for
Cw6 and B57 but negative for both DRB1*0701 and
DQB1*03032 and to carry the class II end of this hap-
lotype if the converse was true.
Results
The U.S. and German cohorts were comparable in
terms of percentages of males and females affected (table
1). The percentage of affected parents (37%–44%) was
higher than that previously reported for juvenile-onset
psoriasis overall (13.5%) (Christophers and Henseler
1990). Although the age-at-onset criterion was applied
only to probands, 191% of the affected relatives of the
probands also were !40 years of age at onset, compared
with 73% of unrelated psoriatic individuals (Henseler
and Christophers 1985).
Parametric two-point linkage calculations performed
under the assumption of marker-trait equilibrium re-
vealed only weak evidence for linkage under dominant
or recessive models (LOD X0.7), and there also was no
evidence for sharing of HLA alleles, among affected sib-
lings, at any HLA locus (table 2A). However, maximum
LOD scores (Zmax) increased markedly after we ac-
counted for linkage disequilibrium between the marker
and the trait, particularly for HLA-C and -B (table 2).
The largest increases in Zmax—from 0.06 at recombi-
nation fraction to 8.43 at —were ob-v  .41 v  .16
served under the dominant model, for HLA-C. These
results were obtained by use of a sample of unrelated
affected individuals from our pedigrees to define disease-
marker haplotype frequencies, which is a potential
source of bias (Chakravarti et al. 1984). Therefore, we
repeated these calculations for HLA-A and -B, using an
independent sample of unrelated German psoriatics, to
estimate disease-marker haplotype frequencies. LOD
scores obtained for HLA-B again increased markedly
under the assumptions of dominance and marker-trait
linkage disequilibrium, whereas those obtained for
HLA-A did not (table 2B).
When applied to all informative parent-offspring trios,
the TDT is also a test for linkage in the presence of
linkage disequilibrium. When used in this fashion, the
TDT confirmed the parametric linkage results (table 3):
P values obtained for HLA-C and -B were much more
significant than those obtained for HLA-DRB1 and
-DQB1, and the results obtained for HLA-A were not
significant at the level.P  .05
When all trios studied are independent (i.e., derived
from different families), the TDT is a test of linkage
disequilibrium (Spielman and Ewens 1996). We identi-
fied risk alleles at each locus, using two overlapping but
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Table 2
Allele Sharing and Parametric Linkage Results (ILINK) for HLA Markers
HLA
MARKER
DISTANCE
FROM
HLA-Aa
(Mb)
HETERO-
ZYGOSITY
AFFECTED-
SIB-PAIR
LOD
SCOREb
DOMINANT MODEL RECESSIVE MODEL
Marker-
Trait
Equilib-
rium
Marker-
Trait
Disequilib-
rium
Marker-
Trait
Equilib-
rium
Marker-
Trait
Disequilib-
rium
Zmax vmax Zmax vmax Zmax vmax Zmax vmax
A. Pooled U.S. and German Cohortsc
A .0 .84 .138 .474 .29 2.106 .23 .000 .50 .858 .26
C 1.3 .84 .000 .064 .41 8.435 .16 .159 .30 1.983 .30
B 1.4 .92 .011 .705 .32 6.228 .23 .000 .50 1.259 .32
DRB1 2.2 .87 .157 .605 .33 2.761 .28 .323 .26 2.333 .22
DQB1 2.3 .82 .150 .198 .38 2.998 .25 .706 .19 1.747 .19
B. German Cohort Onlyd
A .0 .84 ) .075 .35 .890 .20 .000 .50 .035 .45
B 1.4 .92 ) .586 .29 5.259 .14 .004 .44 .770 .36
a Map distances are from the physical map of the HLA region (Campbell and Trowsdale 1993) and are expressed
to the nearest 0.1 Mb.
b Calculated from pooled U.S. and German cohorts, by use of the SIBPAIR program from the ANALYZE
package (Satsangi et al. 1996). Data shown include downweighting for multiple sib pairs in a sibship.
c Marker-trait–equilibrium data were calculated by use of marker allele frequencies generated from pooled
U.S. and German founder individuals, under the assumption of linkage equilibrium between marker and trait
loci. Marker-trait–disequilibrium data were calculated by use of case sample 1 and pooled local controls to
generate marker-disease haplotype frequencies, as described in Subjects and Methods.
d Marker-trait–equilibrium data were calculated by use of marker allele frequencies generated from German
founder individuals, under the assumption of linkage equilibrium between marker and trait loci. Marker-
trait–disequilibrium data were calculated by use of case sample 2 and German local controls to generate marker-
disease haplotype frequencies, as described in Subjects and Methods.
complementary methods: the TDT, performed using only
one randomly selected trio per pedigree, and case-control
association analysis. Both studies revealed that the most
strongly associated alleles/phenotypes were Cw6, B57,
DRB1*0701 (DR7), and DQB1*03032 (DQ9) (tables 3
and 4). Case-control testing revealed very similar results
for the U.S. and German cohorts (table 4). In both co-
horts, the most significant results were obtained for
HLA-Cw6.
Although the foregoing results generally favored the
class I loci HLA-B and -C over the class II loci HLA-
DRB1 and -DQB1, none of these tests could exclude
involvement of a gene in the class II region. In an effort
to address this question, we compared disease preva-
lence among individuals carrying fragments of the
EH57.1 ancestral haplotype (Cw6–B57–DRB1*0701–
DQB1*03032). It was notable that 35 (11.8%) of 296
affected individuals selectively retained only the class I
end of this haplotype, compared with only 12 (3.4%)
of 347 unaffected individuals. In contrast, only 9 (3.0%)
affected and 6 (1.7%) unaffected individuals selectively
retained the class II end of this haplotype. Of the 9
affected individuals selectively retaining the class II end,
5 unrelated persons were extracted. Of these, 4 carried
Cw6 (3 in trans and 1 in cis). This trend was reversed
among the unrelated unaffected individuals, since 3/4
were Cw6 negative.
Discussion
The presence of a disease gene in the HLA region has
long been suspected, on the basis of HLA-association
studies (reviewed in Elder et al. 1994). However, the
precise genetic basis of HLA association in psoriasis has
remained elusive, as it has in other autoimmune disor-
ders. Previous studies based on limited numbers of fam-
ilies found only weak evidence (Russell et al. 1972; Kar-
vonen et al. 1976; Civatte et al. 1977; Suarez-Almazor
and Russell 1990; Lin et al. 1991; Cao et al. 1993; Tom-
fohrde et al. 1994) or no evidence (Lin et al. 1991) for
linkage to the HLA region. Recently, stronger evidence
for linkage to the HLA region has been found in the
context of two genome scans, including a scan per-
formed in our laboratory (Nair et al. 1997; Trembath
et al. 1997).
Given that HLA associations are well established for
psoriasis and that linkage disequilibrium is the most
common explanation for allelic association, it was cu-
rious that our genome scan yielded only suggestive ev-
idence for linkage to the HLA region, under two-point
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Table 3
TDT Results
HLA
MARKER
(telrcen)
DISTANCE
FROM
HLA-Aa
(Mb)
HETERO-
ZYGOSITY
RISK
ALLELEb
ALL TRIOS ONE TRIO PER FAMILY
T:NTc
Best Allele
P Valued
Multiallelic
P Valuee T:NTc
Best Allele
P Valued
Multiallelic
P Valuee
A .0 .84 ) ) 1.00 .54 ) 1.00 .62
C 1.3 .84 Cw6 85:32 .0000086 .000012 38:13 .0023 .000040
B 1.4 .92 B57 61:14 .00000097 .0000028 27:3 .000082 .012
DRB1 2.2 .87 DR7 86:39 .00024 .0013 44:10 .000029 .000086
DQB1 2.3 .82 DQ9 40:13 .0015 .0053 22:6 .015 .00678
a Map distances are from the physical map of the HLA region (Campbell and Trowsdale 1993) and are expressed to the
nearest 0.1 Mb.
b Most significant risk allele identified by the biallelic TDT.
c Ratio of transmitted (T) to nontransmitted (NT) alleles from heterozygous parents.
d Corrected for number of valid biallelic TDT tests performed at the locus (Spielman et al. 1993).
e Calculated over all alleles at the indicated locus, by use of a multiallelic extension of the TDT (Spielman and Ewens 1996).
parametric linkage analysis ( at , forZ  2.59 v  .14max
TNFB, a marker mapping just 5′ to the tumor necrosis
factor-b gene), and that little, if any, evidence for linkage
emerged from two-point or multipoint analysis of allele
sharing (SIBPAIR and GENEHUNTERP  .026 P 
, for D6S291; SIBPAIR and GENE-.022 P  .011
HUNTER , for TNFB) (Nair et al. 1997).P  .059
Moreover, since most individuals carrying HLA risk al-
leles are heterozygous for these alleles (Russell et al.
1972; Karvonen et al. 1976; Civatte et al. 1977), it also
was curious that the mode of inheritance under which
we found evidence for linkage to HLA in the genome
scan was recessive rather than dominant. Inspection of
our pedigrees revealed many asymptomatic carriers of
Cw6 among the founders and unaffected spouses, with
numerous examples of transmission of this allele to af-
fected individuals. A typical example is shown in figure
1. Previously published family studies had not reported
this phenomenon (Russell et al. 1972; Karvonen et al.
1976; Civatte et al. 1977), perhaps because such families
were considered to be bilineal for the disease chromo-
some and therefore may have been excluded. However,
it is not surprising that this situation arose, given that
the allele frequency of Cw6 was substantial in both sets
of local controls (9.3% in the German cohort and 9.9%
in the U.S. cohort) and that our ascertainment criteria
were intentionally biased toward multiplex involvement.
Given that Cw6 is associated with disease when found
on at least three HLA-B-Cw6 haplotypes (Cw6-B13,
Cw6-B37, and Cw6-B57), it seems reasonable to assume
that many, if not all, Cw6-positive individuals are car-
riers of the disease allele (see below). However, only
∼10% of Cw6-positive individuals are affected, presum-
ably owing to lack of other genetic and/or environmental
factors (reviewed in Elder et al. 1994). This assumption
is incorporated into our parametric model by the low
penetrance (9%) and high frequency (5%) specified for
the disease allele. However, unless the phase of the dis-
ease allele is specified correctly, the power of the linkage
analysis is greatly reduced, even for a fully penetrant
disorder (Clerget-Darpoux 1982). By combination of
low penetrance with appropriate specification of phase,
the linkage parameters much more closely approach the
actual situation encountered in our pedigrees, as ex-
emplified in figure 1. Consistent with the fact that most
Cw6-positive psoriatics carry only one copy of this allele,
incorporation of marker-trait disequilibrium not only
markedly increased the LOD score but also changed the
apparent mode of inheritance, from recessive (as was
suggested by our genome scan) to dominant.
Case-control association tests and the TDT both
yielded risk alleles very similar to those identified by
previous case-control association studies of Caucasian
populations. Since only one-third of psoriatics are aware
of an affected relative (Farber and Nall 1974), most prior
association studies can be assumed to be comprised of
mainly “sporadic” cases. Therefore, our results argue
against any meaningful distinction between “familial”
and “sporadic” psoriasis, at least in terms of the HLA-
linked component.
Our study yielded relatively strong associations with
HLA-DR7, as have numerous prior case-control studies.
This result may be explained by the fact that the an-
cestral haplotype EH13.1, carrying Cw6 and B13, also
encodes DR7 (DRB1*0701) (Degli-Esposti et al. 1992).
The existence of these two psoriasis-associated ancestral
haplotypes probably explains why the number of TDT
transmission events involving Cw6 and DR7 greatly out-
number those involving B57 and DQ9 (table 3). The
association of psoriasis with at least two ancestral hap-
lotypes carrying the same alleles at HLA-C and -DRB1
would appear to be inconsistent with linkage outside the
C–DR interval, even after allowing for recent population
expansion and endogamy (Thompson and Neel 1997).
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Table 4
2 # 2 Contingency Tests for Association of Selected HLA
Phenotypes with Psoriasis
Phenotype
Relative
Risk Pearson x2 P Valuea
Corrected
P Valueb
A. U.S. Cohort
A1 1.70 2.73 .13 1.00
A2 .93 .06 .87 1.00
B13 2.62 4.62 .06 1.00
B37 3.79 2.93 .12 1.00
B39 .35 1.07 .46 1.00
B57 7.91 28.68 61.6# 10 53.8# 10
Cw6 6.55 34.72 81.9# 10 74.6# 10
Cw7 .54 3.93 .06 1.00
DR7c 2.80 9.54 33.8# 10 .09
DR10 2.07 .36 .48 1.00
DQ9d 5.82 16.65 41.6# 10 33.8# 10
73Alae 2.81 2.89 .10 1.00
B. German Cohort
A1 1.23 .49 .55 1.00
A2 2.05 6.24 .02 .37
B13 4.69 12.91 45.5# 10 .013
B37 2.39 1.54 .31 1.00
B39 2.39 1.54 .31 1.00
B57 9.02 30.50 82.7# 10 76.5# 10
Cw6 15.11 53.08 10! 5# 10 8! 1.2# 10
Cw7 1.00 .00 1.00 1.00
DR7c 4.28 22.91 62.0# 10 54.8# 10
DR10 1.33 .08 1.00 1.00
DQ9d 3.92 13.57 43.1# 10 37.4# 10
73Alae 4.68 11.87 49.1# 10 22.2# 10
a As determined by use of Fisher’s exact test.
b Bonferroni correction applied for 24 tests (12 on the U.S. cohort
and 12 on the German cohort).
c DR7 phenotype denotes one or two copies of the DRB1*0701
genotype.
d DQ9 phenotype denotes one or two copies of the DQB1*03032
genotype.
e Defined as phenotypically positive for Cw4, Cw6, Cw7, Cw12,
Cw13, or Cw15.
Figure 1 Psoriasis pedigree, demonstrating segregation of HLA
haplotypes, determined as described in Subjects and Methods. Note
four transmissions of Cw6 from married-ins in the second generation
(boxed haplotypes), generating two apparent recombination events
(marked by asterisks [*]).
However, the two haplotypes differ in their intervening
class III and HLA-B alleles (Degli-Esposti et al. 1992),
suggesting that further localization should be possible.
Because we have followed transmission of HLA hap-
lotypes through families, we have been able to identify
recombinant ancestral haplotypes with confidence. We
have used these “broken” haplotypes to confirm prior
case-control studies (Schmitt-Egenolf et al. 1996), in
which the recombinant haplotypes could only be in-
ferred. By studying individuals carrying recombinants of
EH57.1, we found that the class I end of this haplotype
was selectively retained among affected individuals
nearly four times more often than among unaffected
individuals and that nearly all of the few affected indi-
viduals who carry only the class II end of this haplotype
also carried Cw6 (usually in trans). Statistical analysis
of these results was not possible, because of the limited
number of genetically independent individuals carrying
suitable fragments of the EH57.1 haplotype. Neverthe-
less, our results are very consistent with those of Schmitt-
Egenolf et al. (1996), who found a highly significant
result by use of a case-control design. However, at pres-
ent, we cannot rule out the possibility that a second
determinant may reside in the class II region.
In agreement with prior association studies, the family
data presented here all point to HLA-Cw6 as the strong-
est predictor of psoriasis risk, among the HLA alleles
tested. However, we believe that Cw6 is unlikely to be
the direct determinant of susceptibility, for three reasons:
First, only one Cw6 coding sequence has been identified,
and, yet, three psoriasis-associated B-Cw6 haplotypes do
not carry equal risk in any given population. Second,
the risk of psoriasis as a function of the B-Cw6 haplotype
varies from population to population. Thus, B13-Cw6
and B37-Cw6 are the strongest B-Cw6 risk haplotypes
inferred from Japanese association studies (Tsuji et al.
1979; Nakagawa et al. 1991), whereas Cw6-B57 is pre-
dominant in Caucasian (table 4) (Tiwari and Terasaki
1985) and Chinese (Cao et al. 1993) populations. Third,
if HLA-C is the direct determinant of susceptibility, this
would imply that more than one allele at HLA-C must
predispose to disease (under the assumption of locus
homogeneity). However, our study alone has identified
1100 examples of Cw6-negative psoriatics. Prompted by
the high prevalence of HLA-Cw7 in Japanese psoriatics
(Nakagawa et al. 1991; Muto et al. 1995), Asahina et
al. (1991) suggested that the presence of alanine (rather
than threonine) at amino acid residue 73 of HLA-C
(73Ala) confers risk for psoriasis. 73Ala is present in
alleles Cw4, Cw6, Cw7, Cw12, Cw13, and Cw15 and
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therefore is found in at least two-thirds of Caucasian
HLA-C molecules (Bunce et al. 1996). Although a weak
association with 73Ala was identified in the German
cohort, there was no association with this collection of
alleles in the U.S. cohort (table 4). Moreover, neither
association tests nor the TDT supported involvement of
Cw7 in our pedigrees. Overall, the most parsimonious
explanation for our results is that the disease determi-
nant is neither 73Ala nor any feature of HLA-C itself
but that it is an allele at a locus in very tight disequilib-
rium with HLA-Cw6. If so, the variability in identity of
the accompanying HLA-B alleles could be explained by
ancestral recombination or gene-conversion events that
are more recent than the emergence of the disease allele,
and the variation in relative risk associated with each
B-Cw6 haplotype could reflect haplotype-specific vari-
ants of the disease allele, variations in population prev-
alence of the susceptibility haplotypes, or both.
Recombination in the vicinity of the B and C alleles
would have to be very rare in order to preserve the
observed associations between these loci and the disease
allele in diverse world populations. This would be con-
sistent with the emerging concept that the HLA region
is composed of five “polymorphic frozen blocks,” within
which recombination appears to be strongly suppressed
(Marshall et al. 1993). Our data suggest that a major
psoriasis-susceptibility locus resides within the b block,
which extends from just telomeric to TNFB to ≈100 kb
telomeric to HLA-C (Marshall et al. 1993). This region
contains a high density of genes (Leelayuwat et al. 1995),
several of which are polymorphic and in strong linkage
disequilibrium with known B-C haplotypes (Foissac et
al. 1997). Recently, one of the genes within the b block,
known as “MICA” or “PERB11,” has been shown to
display a near-perfect association with Behc¸et disease
(Mizuki et al. 1997). We predict that a similar scenario
will emerge for psoriasis, when the correct locus within
the b block is identified.
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